← Eichor
Condition: Retinopathy Diabetic Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Retinopathy Diabetic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Natural Course Progression of Diabetic Retinopathy
Phase N/A · 1 location(s) · Jie Li · NCT06269419Defining Retinal Structures Using Hyperspectral Retinal Imaging
NA · 1 location(s) · Center for Eye Research Australia · NCT07555574The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
EARLY_Phase 1 · 1 location(s) · MCPHS University · NCT06593405Intraoperative OCT Guidance of Intraocular Surgery II
Phase N/A · 1 location(s) · Duke University · NCT03713268Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab
NA · 1 location(s) · Osijek University Hospital · NCT07520045A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Phase 2 · 26 location(s) · Vantage Biosciences Ltd · NCT06770933Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
NA · 1 location(s) · Steno Diabetes Center Greenland · NCT06264427High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Phase 4 · 1 location(s) · Retina Consultants of Orange County · NCT06662994Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathie
NA · 1 location(s) · CHU de Reims · NCT03680794Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes
NA · 1 location(s) · University Hospital, Motol · NCT07149142Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus
NA · 1 location(s) · VUNO Inc. · NCT07378956Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
Phase N/A · 2 location(s) · IRCCS Ospedale San Raffaele · NCT06582472A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · 80 location(s) · Boehringer Ingelheim · NCT06962839Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment
NA · 1 location(s) · Fondazione G.B. Bietti, IRCCS · NCT07500324Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
Phase N/A · 1 location(s) · Li Xiaorong · NCT06478407Glaucoma Screening Using Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program
NA · 1 location(s) · Singapore Eye Research Institute · NCT07243665Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
NA · 1 location(s) · Vastra Gotaland Region · NCT06549023Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT07722910Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2/Phase 3 · 1 location(s) · Isfahan University of Medical Sciences · NCT06595355A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
Phase 3 · 1 location(s) · Incepta Pharmaceuticals Ltd · NCT06305416Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Phase 2 · 1 location(s) · Qlaris Bio, Inc. · NCT07354477Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
Phase N/A · 3 location(s) · Yufan Wang · NCT06821399Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT03403686Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
NA · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06124586Village-Integrated Eye Worker Trial II
NA · 1 location(s) · University of California, San Francisco · NCT03752840Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and R
Phase N/A · 1 location(s) · Hywel Dda Health Board · NCT06914778Diabetic Retinopathy Prevalence And Risk Factors
Phase N/A · 1 location(s) · Da Nang Family General Hospital · NCT07468058Exploring the Effectiveness of AI Generative Models for Diabetic Patients
Phase N/A · 1 location(s) · Pakistan Council of Scientific and Industrial Research · NCT05883072Effect of Video Viewing on Intravitreal Injection Experience
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07002372Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab
Phase N/A · 1 location(s) · Ataturk University · NCT07550777
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.